You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 135 No. 3, March 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Head & Neck Cancer
 •Neoplasms of Head & Neck
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

7β-Hydroxycholesterol Induces Apoptosis and Regulates Cyclooxygenase 2 in Head and Neck Squamous Cell Carcinoma

Gregor Heiduschka, MD; Boban M. Erovic, MD; Laurenz Vormittag, MD; Christiane Skoda, MD; Helga Martinek; Markus Brunner, MD; Klaus Ehrenberger, MD; Dietmar Thurnher, MD

Arch Otolaryngol Head Neck Surg. 2009;135(3):261-267.

Objective  To determine whether treatment with 7β-hydroxycholesterol (7β-HC) would trigger cell death in head and neck squamous cell carcinoma (HNSCC) cell lines in a dose-dependent fashion.

Design  In vitro study.

Subjects  The study included HNSCC cell lines SCC9, SCC25, CAL27, and FaDu.

Intervention  We treated HNSCC cell lines with increasing doses of 7β-HC. Proliferation assays were performed to assess cell viability after treatment. Western blots were carried out to evaluate cyclooxygenase (COX)-1 and -2 expression levels.

Results  Using proliferation assays and immunocytochemical analysis, we detected significant growth inhibition via apoptosis in 4 different HNSCC cell lines after treatment with 7β-HC (P < .001). The 50% inhibitory concentration levels were between 13.19 and 20.79 µmol/L after 72 hours. Western analysis indicated that COX-2, but not COX-1, levels were suppressed after treatment.

Conclusions  Treatment with 7β-HC resulted in suppression of HNSCC growth in vitro. Our data warrant further investigations for the potential use of 7β-HC as a cytotoxic agent in head and neck cancer.


Author Affiliations: Departments of Otorhinolaryngology–Head and Neck Surgery (Drs Heiduschka, Erovic, Brunner, Ehrenberger, and Thurnher and Ms Martinek), Internal Medicine I, Division of Oncology (Dr Vormittag), and Radiotherapy and Radiobiology (Dr Skoda), Medical University of Vienna, Vienna, Austria.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.